These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24703799)

  • 1. Bilateral giant coronary aneurysms in a 40-year-old male with Noonan syndrome caused by a KRAS germline mutation.
    Fujimoto N; Nakajima H; Sugiura E; Dohi K; Kanemitsu S; Yamada N; Aoki Y; Nakatani K; Shimpo H; Nobori T; Ito M
    Int J Cardiol; 2014 May; 173(3):e63-6. PubMed ID: 24703799
    [No Abstract]   [Full Text] [Related]  

  • 2. Noonan syndrome and systemic lupus erythematosus in a patient with a novel KRAS mutation.
    Leventopoulos G; Denayer E; Makrythanasis P; Papapolychroniou C; Fryssira H
    Clin Exp Rheumatol; 2010; 28(4):556-7. PubMed ID: 20810036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal detection of Noonan syndrome by mutation analysis of the PTPN11 and the KRAS genes.
    Houweling AC; de Mooij YM; van der Burgt I; Yntema HG; Lachmeijer AM; Go AT
    Prenat Diagn; 2010 Mar; 30(3):284-6. PubMed ID: 20112233
    [No Abstract]   [Full Text] [Related]  

  • 4. Noonan syndrome caused by germline KRAS mutation in Taiwan: report of two patients and a review of the literature.
    Lo FS; Lin JL; Kuo MT; Chiu PC; Shu SG; Chao MC; Lee YJ; Lin SP
    Eur J Pediatr; 2009 Aug; 168(8):919-23. PubMed ID: 18958496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes.
    Brasil AS; Pereira AC; Wanderley LT; Kim CA; Malaquias AC; Jorge AA; Krieger JE; Bertola DR
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):425-32. PubMed ID: 20578946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical coronary artery aneurysms due to Kawasaki disease in Noonan syndrome with a novel PTPN11 mutation.
    Takai S; Takasawa K; Doi S
    Cardiol Young; 2019 Feb; 29(2):228-230. PubMed ID: 30511597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lethal course of hypertrophic cardiomyopathy in Noonan syndrome due to a novel germline mutation in the KRAS gene: case study.
    Nosan G; Bertok S; Vesel S; Yntema HG; Paro-Panjan D
    Croat Med J; 2013 Dec; 54(6):574-8. PubMed ID: 24382853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two novel germline KRAS mutations: expanding the molecular and clinical phenotype.
    Stark Z; Gillessen-Kaesbach G; Ryan MM; Cirstea IC; Gremer L; Ahmadian MR; Savarirayan R; Zenker M
    Clin Genet; 2012 Jun; 81(6):590-4. PubMed ID: 21797849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the genetic spectrum of Noonan syndrome.
    Noordam K
    Horm Res; 2007; 68 Suppl 5():24-7. PubMed ID: 18174700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No reason yet to change diagnostic criteria for Noonan, Costello and cardio-facio-cutaneous syndromes.
    Neri G; Allanson J; Kavamura MI
    J Med Genet; 2008 Dec; 45(12):832. PubMed ID: 19047498
    [No Abstract]   [Full Text] [Related]  

  • 11. Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders.
    Gremer L; Merbitz-Zahradnik T; Dvorsky R; Cirstea IC; Kratz CP; Zenker M; Wittinghofer A; Ahmadian MR
    Hum Mutat; 2011 Jan; 32(1):33-43. PubMed ID: 20949621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile myelomonocytic leukemia in a 16-year-old with Noonan syndrome: case report.
    Ortiz MV; Skoda-Smith S; Rauen KA; Allan RW; Slayton WB
    J Pediatr Hematol Oncol; 2012 Oct; 34(7):569-72. PubMed ID: 22510777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS gene mutations in Noonan syndrome familial cases cluster in the vicinity of the switch II region of the G-domain: report of another family with metopic craniosynostosis.
    Brasil AS; Malaquias AC; Kim CA; Krieger JE; Jorge AA; Pereira AC; Bertola DR
    Am J Med Genet A; 2012 May; 158A(5):1178-84. PubMed ID: 22488932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External ear anomalies and hearing impairment in Noonan Syndrome.
    van Trier DC; van Nierop J; Draaisma JMT; van der Burgt I; Kunst H; Croonen EA; Admiraal RJC
    Int J Pediatr Otorhinolaryngol; 2015 Jun; 79(6):874-878. PubMed ID: 25862627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Craniosynostosis in patients with Noonan syndrome caused by germline KRAS mutations.
    Kratz CP; Zampino G; Kriek M; Kant SG; Leoni C; Pantaleoni F; Oudesluys-Murphy AM; Di Rocco C; Kloska SP; Tartaglia M; Zenker M
    Am J Med Genet A; 2009 May; 149A(5):1036-40. PubMed ID: 19396835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Noonan syndrome phenotype associated with a germline Q71R MRAS variant: a recurrent substitution in RAS homologs in various cancers.
    Suzuki H; Takenouchi T; Uehara T; Takasago S; Ihara S; Yoshihashi H; Kosaki K
    Am J Med Genet A; 2019 Aug; 179(8):1628-1630. PubMed ID: 31173466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.
    Tidyman WE; Rauen KA
    Expert Rev Mol Med; 2008 Dec; 10():e37. PubMed ID: 19063751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The face of Noonan syndrome: Does phenotype predict genotype.
    Allanson JE; Bohring A; Dörr HG; Dufke A; Gillessen-Kaesbach G; Horn D; König R; Kratz CP; Kutsche K; Pauli S; Raskin S; Rauch A; Turner A; Wieczorek D; Zenker M
    Am J Med Genet A; 2010 Aug; 152A(8):1960-6. PubMed ID: 20602484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why should medical editors CARE about case reports?
    Barić H; Andrijašević L
    Croat Med J; 2013 Dec; 54(6):507-9. PubMed ID: 24382844
    [No Abstract]   [Full Text] [Related]  

  • 20. Deregulated Ras signaling in developmental disorders: new tricks for an old dog.
    Schubbert S; Bollag G; Shannon K
    Curr Opin Genet Dev; 2007 Feb; 17(1):15-22. PubMed ID: 17208427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.